Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China; Med+X Center for Manufacturing, West China Hospital, Sichuan University, Chengdu, 610041, China.
Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, 610041, China; Center for Translational Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital, Sichuan University, Chengdu, 610041, China; Laboratory of Metabolomics and Gynecological Disease Research, West China Second University Hospital, Sichuan University, Chengdu, 610041, China.
Biosens Bioelectron. 2024 Mar 15;248:115968. doi: 10.1016/j.bios.2023.115968. Epub 2023 Dec 22.
Screening for high-risk human papillomavirus (HPV) infection is one of the most important preventative measures for cervical cancer. However, fast, convenient, and low-cost HPV detection remains challenging, especially in resource-limited settings. Here, we report a portable all-in-one device (PAD) for point-of-care testing (POCT) for HPV16 and HPV18 DNA in cervical swabs. The PAD was engineered to integrate modules for extraction-free sample lysis, loop-mediated isothermal amplification (LAMP) with lyophilized reagent beads, and real-time colorimetric signal sensing into a single miniaturized device, considerably shortening the sample-to-result time to 15 min. The precision liquid handling in the completely sealed microfluidic chip is achieved by a uniquely designed pressure-balanced automatic liquid flow mechanism, thereby eliminating the need for manual manipulation of liquids and thus the risk of biohazards. The PAD employs an improved real-time colorimetric LAMP (rcLAMP) assay with a limit of detection (LOD) of 1 copy/μL, enabled by enhanced assay chemistry to maximize the reaction kinetics. To validate this device for clinical application, we tested 206 clinical cervical swab samples and obtained a sensitivity of 92.1% and a specificity of 99.0%. This custom PAD enabled by microfluidic and electronic engineering techniques can be configured for the simultaneous detection of HPV16 and HPV18 or other pathogens in point-of-care applications.
筛查高危型人乳头瘤病毒(HPV)感染是预防宫颈癌的最重要措施之一。然而,快速、方便且低成本的 HPV 检测仍然具有挑战性,尤其是在资源有限的环境中。在这里,我们报告了一种用于即时护理测试(POCT)的便携式一体式设备(PAD),可用于检测宫颈拭子中的 HPV16 和 HPV18 DNA。该 PAD 经过设计,可将用于无提取样品裂解、冻干试剂珠环介导等温扩增(LAMP)以及实时比色信号感应的模块集成到单个小型化设备中,大大缩短了从样品到结果的时间,仅需 15 分钟。完全密封的微流控芯片中的精密液体处理通过独特设计的压力平衡自动液体流动机制来实现,从而消除了对液体的手动操作的需求,从而降低了生物危害的风险。该 PAD 采用了改进的实时比色 LAMP(rcLAMP)检测法,检测限(LOD)为 1 拷贝/μL,通过增强的检测化学方法实现了反应动力学的最大化,从而提高了检测灵敏度。为了验证该设备在临床应用中的性能,我们测试了 206 例临床宫颈拭子样本,获得了 92.1%的灵敏度和 99.0%的特异性。这种基于微流控和电子工程技术的定制 PAD 可用于同时检测 POCT 应用中的 HPV16 和 HPV18 或其他病原体。